nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—Buclizine—Imatinib—hematologic cancer	0.288	1	CrCrCtD
Fexofenadine—ABCB1—hematologic cancer	0.0997	1	CbGaD
Fexofenadine—SLCO1A2—Chlorambucil—hematologic cancer	0.0606	0.148	CbGbCtD
Fexofenadine—SLCO1A2—Prednisolone—hematologic cancer	0.0229	0.0561	CbGbCtD
Fexofenadine—SLCO1A2—Prednisone—hematologic cancer	0.0216	0.053	CbGbCtD
Fexofenadine—ABCB1—Lenalidomide—hematologic cancer	0.0198	0.0484	CbGbCtD
Fexofenadine—SLCO1B1—Irinotecan—hematologic cancer	0.0193	0.0474	CbGbCtD
Fexofenadine—SLCO1B3—Methotrexate—hematologic cancer	0.0176	0.043	CbGbCtD
Fexofenadine—CYP2D6—Lomustine—hematologic cancer	0.0173	0.0424	CbGbCtD
Fexofenadine—CYP2D6—Idarubicin—hematologic cancer	0.0154	0.0378	CbGbCtD
Fexofenadine—SLCO1A2—Dexamethasone—hematologic cancer	0.0135	0.0331	CbGbCtD
Fexofenadine—CYP2D6—Hydroxyurea—hematologic cancer	0.0131	0.0321	CbGbCtD
Fexofenadine—ABCB1—Daunorubicin—hematologic cancer	0.0116	0.0284	CbGbCtD
Fexofenadine—CYP2D6—Bortezomib—hematologic cancer	0.0114	0.0279	CbGbCtD
Fexofenadine—ABCB1—Alitretinoin—hematologic cancer	0.0113	0.0278	CbGbCtD
Fexofenadine—SLCO1A2—Methotrexate—hematologic cancer	0.0109	0.0266	CbGbCtD
Fexofenadine—SLCO1B1—Methotrexate—hematologic cancer	0.0102	0.0251	CbGbCtD
Fexofenadine—ABCB1—Imatinib—hematologic cancer	0.00887	0.0217	CbGbCtD
Fexofenadine—CYP2D6—Imatinib—hematologic cancer	0.00836	0.0205	CbGbCtD
Fexofenadine—ABCB1—Nilotinib—hematologic cancer	0.00806	0.0197	CbGbCtD
Fexofenadine—ABCB1—Vinorelbine—hematologic cancer	0.00799	0.0196	CbGbCtD
Fexofenadine—CYP2D6—Nilotinib—hematologic cancer	0.0076	0.0186	CbGbCtD
Fexofenadine—CYP2D6—Vinorelbine—hematologic cancer	0.00753	0.0184	CbGbCtD
Fexofenadine—ABCB1—Dasatinib—hematologic cancer	0.00713	0.0174	CbGbCtD
Fexofenadine—ABCB1—Mitoxantrone—hematologic cancer	0.00704	0.0172	CbGbCtD
Fexofenadine—ABCB1—Betamethasone—hematologic cancer	0.00627	0.0154	CbGbCtD
Fexofenadine—ABCB1—Gemcitabine—hematologic cancer	0.00622	0.0152	CbGbCtD
Fexofenadine—ABCB1—Prednisolone—hematologic cancer	0.00619	0.0152	CbGbCtD
Fexofenadine—ABCB1—Prednisone—hematologic cancer	0.00585	0.0143	CbGbCtD
Fexofenadine—ABCB1—Irinotecan—hematologic cancer	0.00554	0.0136	CbGbCtD
Fexofenadine—ABCB1—Vinblastine—hematologic cancer	0.00493	0.0121	CbGbCtD
Fexofenadine—ABCB1—Vincristine—hematologic cancer	0.00484	0.0119	CbGbCtD
Fexofenadine—CYP2D6—Vinblastine—hematologic cancer	0.00464	0.0114	CbGbCtD
Fexofenadine—ABCB1—Cisplatin—hematologic cancer	0.00452	0.0111	CbGbCtD
Fexofenadine—ABCB1—Etoposide—hematologic cancer	0.00444	0.0109	CbGbCtD
Fexofenadine—ABCB1—Dexamethasone—hematologic cancer	0.00365	0.00894	CbGbCtD
Fexofenadine—CYP2D6—Dexamethasone—hematologic cancer	0.00344	0.00842	CbGbCtD
Fexofenadine—ABCB1—Doxorubicin—hematologic cancer	0.00303	0.00741	CbGbCtD
Fexofenadine—ABCB1—Methotrexate—hematologic cancer	0.00293	0.00718	CbGbCtD
Fexofenadine—CYP2D6—Doxorubicin—hematologic cancer	0.00285	0.00698	CbGbCtD
Fexofenadine—SLCO1B3—lung—hematologic cancer	0.000614	0.101	CbGeAlD
Fexofenadine—SLCO1B1—hematopoietic system—hematologic cancer	0.000611	0.1	CbGeAlD
Fexofenadine—SLCO2B1—hematopoietic system—hematologic cancer	0.00054	0.0886	CbGeAlD
Fexofenadine—SLCO1A2—hematopoietic system—hematologic cancer	0.000497	0.0815	CbGeAlD
Fexofenadine—SLCO1B1—blood—hematologic cancer	0.000405	0.0664	CbGeAlD
Fexofenadine—SLCO2B1—lung—hematologic cancer	0.000314	0.0515	CbGeAlD
Fexofenadine—HRH1—hematopoietic system—hematologic cancer	0.000304	0.0499	CbGeAlD
Fexofenadine—SLCO2B1—testis—hematologic cancer	0.000296	0.0486	CbGeAlD
Fexofenadine—SLCO1A2—lung—hematologic cancer	0.000289	0.0474	CbGeAlD
Fexofenadine—SLCO1A2—testis—hematologic cancer	0.000273	0.0447	CbGeAlD
Fexofenadine—CYP2D6—hematopoietic system—hematologic cancer	0.000232	0.038	CbGeAlD
Fexofenadine—SLCO2B1—lymph node—hematologic cancer	0.000215	0.0352	CbGeAlD
Fexofenadine—HRH1—lung—hematologic cancer	0.000177	0.029	CbGeAlD
Fexofenadine—HRH1—testis—hematologic cancer	0.000167	0.0274	CbGeAlD
Fexofenadine—ABCB1—hematopoietic system—hematologic cancer	0.000167	0.0273	CbGeAlD
Fexofenadine—CYP2D6—blood—hematologic cancer	0.000153	0.0252	CbGeAlD
Fexofenadine—CYP2D6—testis—hematologic cancer	0.000127	0.0208	CbGeAlD
Fexofenadine—ABCB1—gonad—hematologic cancer	0.000127	0.0208	CbGeAlD
Fexofenadine—HRH1—lymph node—hematologic cancer	0.000121	0.0198	CbGeAlD
Fexofenadine—ABCB1—blood—hematologic cancer	0.00011	0.0181	CbGeAlD
Fexofenadine—ABCB1—bone marrow—hematologic cancer	0.000107	0.0175	CbGeAlD
Fexofenadine—ABCB1—lung—hematologic cancer	9.67e-05	0.0159	CbGeAlD
Fexofenadine—ABCB1—testis—hematologic cancer	9.13e-05	0.015	CbGeAlD
Fexofenadine—ABCB1—lymph node—hematologic cancer	6.62e-05	0.0109	CbGeAlD
Fexofenadine—Anaphylactic shock—Dexamethasone—hematologic cancer	5.52e-05	0.00036	CcSEcCtD
Fexofenadine—Anaphylactic shock—Betamethasone—hematologic cancer	5.52e-05	0.00036	CcSEcCtD
Fexofenadine—Diarrhoea—Mitoxantrone—hematologic cancer	5.52e-05	0.00036	CcSEcCtD
Fexofenadine—Diarrhoea—Irinotecan—hematologic cancer	5.52e-05	0.00036	CcSEcCtD
Fexofenadine—Vomiting—Carmustine—hematologic cancer	5.52e-05	0.00036	CcSEcCtD
Fexofenadine—Insomnia—Triamcinolone—hematologic cancer	5.5e-05	0.000359	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Etoposide—hematologic cancer	5.48e-05	0.000358	CcSEcCtD
Fexofenadine—Infection—Dexamethasone—hematologic cancer	5.48e-05	0.000358	CcSEcCtD
Fexofenadine—Infection—Betamethasone—hematologic cancer	5.48e-05	0.000358	CcSEcCtD
Fexofenadine—Dizziness—Vincristine—hematologic cancer	5.48e-05	0.000357	CcSEcCtD
Fexofenadine—Rash—Carmustine—hematologic cancer	5.47e-05	0.000357	CcSEcCtD
Fexofenadine—Dermatitis—Carmustine—hematologic cancer	5.46e-05	0.000356	CcSEcCtD
Fexofenadine—Vomiting—Alitretinoin—hematologic cancer	5.46e-05	0.000356	CcSEcCtD
Fexofenadine—Drowsiness—Doxorubicin—hematologic cancer	5.45e-05	0.000356	CcSEcCtD
Fexofenadine—Headache—Carmustine—hematologic cancer	5.43e-05	0.000354	CcSEcCtD
Fexofenadine—Dyspnoea—Triamcinolone—hematologic cancer	5.42e-05	0.000354	CcSEcCtD
Fexofenadine—Rash—Alitretinoin—hematologic cancer	5.42e-05	0.000353	CcSEcCtD
Fexofenadine—Agitation—Prednisone—hematologic cancer	5.41e-05	0.000353	CcSEcCtD
Fexofenadine—Dermatitis—Alitretinoin—hematologic cancer	5.41e-05	0.000353	CcSEcCtD
Fexofenadine—Vomiting—Ifosfamide—hematologic cancer	5.4e-05	0.000352	CcSEcCtD
Fexofenadine—Hypersensitivity—Cisplatin—hematologic cancer	5.39e-05	0.000352	CcSEcCtD
Fexofenadine—Tachycardia—Dexamethasone—hematologic cancer	5.39e-05	0.000351	CcSEcCtD
Fexofenadine—Tachycardia—Betamethasone—hematologic cancer	5.39e-05	0.000351	CcSEcCtD
Fexofenadine—Headache—Alitretinoin—hematologic cancer	5.38e-05	0.000351	CcSEcCtD
Fexofenadine—Angioedema—Prednisone—hematologic cancer	5.38e-05	0.000351	CcSEcCtD
Fexofenadine—Diarrhoea—Gemcitabine—hematologic cancer	5.37e-05	0.00035	CcSEcCtD
Fexofenadine—Nausea—Thalidomide—hematologic cancer	5.36e-05	0.00035	CcSEcCtD
Fexofenadine—Dyspepsia—Triamcinolone—hematologic cancer	5.36e-05	0.000349	CcSEcCtD
Fexofenadine—Rash—Ifosfamide—hematologic cancer	5.35e-05	0.000349	CcSEcCtD
Fexofenadine—Dermatitis—Ifosfamide—hematologic cancer	5.35e-05	0.000349	CcSEcCtD
Fexofenadine—Dizziness—Irinotecan—hematologic cancer	5.33e-05	0.000348	CcSEcCtD
Fexofenadine—Urticaria—Etoposide—hematologic cancer	5.33e-05	0.000347	CcSEcCtD
Fexofenadine—Abdominal pain—Etoposide—hematologic cancer	5.3e-05	0.000346	CcSEcCtD
Fexofenadine—Body temperature increased—Etoposide—hematologic cancer	5.3e-05	0.000346	CcSEcCtD
Fexofenadine—Vomiting—Vincristine—hematologic cancer	5.26e-05	0.000343	CcSEcCtD
Fexofenadine—Urticaria—Prednisolone—hematologic cancer	5.26e-05	0.000343	CcSEcCtD
Fexofenadine—Asthenia—Cisplatin—hematologic cancer	5.25e-05	0.000343	CcSEcCtD
Fexofenadine—Fatigue—Triamcinolone—hematologic cancer	5.25e-05	0.000342	CcSEcCtD
Fexofenadine—Rash—Vincristine—hematologic cancer	5.22e-05	0.00034	CcSEcCtD
Fexofenadine—Dermatitis—Vincristine—hematologic cancer	5.22e-05	0.00034	CcSEcCtD
Fexofenadine—Pain—Triamcinolone—hematologic cancer	5.2e-05	0.000339	CcSEcCtD
Fexofenadine—Headache—Vincristine—hematologic cancer	5.19e-05	0.000338	CcSEcCtD
Fexofenadine—Nausea—Carmustine—hematologic cancer	5.15e-05	0.000336	CcSEcCtD
Fexofenadine—Epistaxis—Doxorubicin—hematologic cancer	5.14e-05	0.000336	CcSEcCtD
Fexofenadine—Vomiting—Mitoxantrone—hematologic cancer	5.13e-05	0.000334	CcSEcCtD
Fexofenadine—Vomiting—Irinotecan—hematologic cancer	5.13e-05	0.000334	CcSEcCtD
Fexofenadine—Sinusitis—Doxorubicin—hematologic cancer	5.12e-05	0.000334	CcSEcCtD
Fexofenadine—Nausea—Alitretinoin—hematologic cancer	5.1e-05	0.000333	CcSEcCtD
Fexofenadine—Rash—Mitoxantrone—hematologic cancer	5.08e-05	0.000332	CcSEcCtD
Fexofenadine—Rash—Irinotecan—hematologic cancer	5.08e-05	0.000332	CcSEcCtD
Fexofenadine—Dermatitis—Irinotecan—hematologic cancer	5.08e-05	0.000331	CcSEcCtD
Fexofenadine—Dermatitis—Mitoxantrone—hematologic cancer	5.08e-05	0.000331	CcSEcCtD
Fexofenadine—Headache—Mitoxantrone—hematologic cancer	5.05e-05	0.000329	CcSEcCtD
Fexofenadine—Headache—Irinotecan—hematologic cancer	5.05e-05	0.000329	CcSEcCtD
Fexofenadine—Nausea—Ifosfamide—hematologic cancer	5.04e-05	0.000329	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	5.03e-05	0.000328	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	5.03e-05	0.000328	CcSEcCtD
Fexofenadine—Myalgia—Prednisone—hematologic cancer	5.01e-05	0.000327	CcSEcCtD
Fexofenadine—Diarrhoea—Cisplatin—hematologic cancer	5.01e-05	0.000327	CcSEcCtD
Fexofenadine—Vomiting—Gemcitabine—hematologic cancer	4.99e-05	0.000326	CcSEcCtD
Fexofenadine—Insomnia—Dexamethasone—hematologic cancer	4.99e-05	0.000326	CcSEcCtD
Fexofenadine—Insomnia—Betamethasone—hematologic cancer	4.99e-05	0.000326	CcSEcCtD
Fexofenadine—Rash—Gemcitabine—hematologic cancer	4.95e-05	0.000323	CcSEcCtD
Fexofenadine—Dermatitis—Gemcitabine—hematologic cancer	4.95e-05	0.000323	CcSEcCtD
Fexofenadine—Hypersensitivity—Etoposide—hematologic cancer	4.94e-05	0.000322	CcSEcCtD
Fexofenadine—Headache—Gemcitabine—hematologic cancer	4.92e-05	0.000321	CcSEcCtD
Fexofenadine—Nausea—Vincristine—hematologic cancer	4.92e-05	0.000321	CcSEcCtD
Fexofenadine—Flushing—Epirubicin—hematologic cancer	4.91e-05	0.00032	CcSEcCtD
Fexofenadine—Hypersensitivity—Prednisolone—hematologic cancer	4.87e-05	0.000318	CcSEcCtD
Fexofenadine—Dyspepsia—Betamethasone—hematologic cancer	4.86e-05	0.000317	CcSEcCtD
Fexofenadine—Dyspepsia—Dexamethasone—hematologic cancer	4.86e-05	0.000317	CcSEcCtD
Fexofenadine—Urticaria—Triamcinolone—hematologic cancer	4.83e-05	0.000315	CcSEcCtD
Fexofenadine—Asthenia—Etoposide—hematologic cancer	4.81e-05	0.000314	CcSEcCtD
Fexofenadine—Body temperature increased—Triamcinolone—hematologic cancer	4.81e-05	0.000314	CcSEcCtD
Fexofenadine—Anaphylactic shock—Prednisone—hematologic cancer	4.81e-05	0.000313	CcSEcCtD
Fexofenadine—Nausea—Mitoxantrone—hematologic cancer	4.79e-05	0.000312	CcSEcCtD
Fexofenadine—Nausea—Irinotecan—hematologic cancer	4.79e-05	0.000312	CcSEcCtD
Fexofenadine—Infection—Prednisone—hematologic cancer	4.78e-05	0.000311	CcSEcCtD
Fexofenadine—Back pain—Methotrexate—hematologic cancer	4.76e-05	0.000311	CcSEcCtD
Fexofenadine—Fatigue—Betamethasone—hematologic cancer	4.76e-05	0.00031	CcSEcCtD
Fexofenadine—Fatigue—Dexamethasone—hematologic cancer	4.76e-05	0.00031	CcSEcCtD
Fexofenadine—Pruritus—Etoposide—hematologic cancer	4.75e-05	0.000309	CcSEcCtD
Fexofenadine—Pain—Dexamethasone—hematologic cancer	4.72e-05	0.000308	CcSEcCtD
Fexofenadine—Pain—Betamethasone—hematologic cancer	4.72e-05	0.000308	CcSEcCtD
Fexofenadine—Tachycardia—Prednisone—hematologic cancer	4.69e-05	0.000306	CcSEcCtD
Fexofenadine—Nausea—Gemcitabine—hematologic cancer	4.67e-05	0.000304	CcSEcCtD
Fexofenadine—Vomiting—Cisplatin—hematologic cancer	4.66e-05	0.000304	CcSEcCtD
Fexofenadine—Vision blurred—Methotrexate—hematologic cancer	4.64e-05	0.000303	CcSEcCtD
Fexofenadine—Rash—Cisplatin—hematologic cancer	4.62e-05	0.000301	CcSEcCtD
Fexofenadine—Dermatitis—Cisplatin—hematologic cancer	4.61e-05	0.000301	CcSEcCtD
Fexofenadine—Diarrhoea—Etoposide—hematologic cancer	4.59e-05	0.000299	CcSEcCtD
Fexofenadine—Flushing—Doxorubicin—hematologic cancer	4.54e-05	0.000296	CcSEcCtD
Fexofenadine—Flatulence—Epirubicin—hematologic cancer	4.54e-05	0.000296	CcSEcCtD
Fexofenadine—Tension—Epirubicin—hematologic cancer	4.52e-05	0.000295	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Betamethasone—hematologic cancer	4.51e-05	0.000294	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.51e-05	0.000294	CcSEcCtD
Fexofenadine—Hypersensitivity—Triamcinolone—hematologic cancer	4.48e-05	0.000292	CcSEcCtD
Fexofenadine—Nervousness—Epirubicin—hematologic cancer	4.47e-05	0.000292	CcSEcCtD
Fexofenadine—Back pain—Epirubicin—hematologic cancer	4.46e-05	0.000291	CcSEcCtD
Fexofenadine—Dizziness—Etoposide—hematologic cancer	4.44e-05	0.000289	CcSEcCtD
Fexofenadine—Urticaria—Betamethasone—hematologic cancer	4.39e-05	0.000286	CcSEcCtD
Fexofenadine—Urticaria—Dexamethasone—hematologic cancer	4.39e-05	0.000286	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.38e-05	0.000286	CcSEcCtD
Fexofenadine—Dizziness—Prednisolone—hematologic cancer	4.37e-05	0.000285	CcSEcCtD
Fexofenadine—Asthenia—Triamcinolone—hematologic cancer	4.37e-05	0.000285	CcSEcCtD
Fexofenadine—Abdominal pain—Betamethasone—hematologic cancer	4.36e-05	0.000285	CcSEcCtD
Fexofenadine—Body temperature increased—Dexamethasone—hematologic cancer	4.36e-05	0.000285	CcSEcCtD
Fexofenadine—Body temperature increased—Betamethasone—hematologic cancer	4.36e-05	0.000285	CcSEcCtD
Fexofenadine—Abdominal pain—Dexamethasone—hematologic cancer	4.36e-05	0.000285	CcSEcCtD
Fexofenadine—Nausea—Cisplatin—hematologic cancer	4.35e-05	0.000284	CcSEcCtD
Fexofenadine—Insomnia—Prednisone—hematologic cancer	4.35e-05	0.000284	CcSEcCtD
Fexofenadine—Vision blurred—Epirubicin—hematologic cancer	4.34e-05	0.000283	CcSEcCtD
Fexofenadine—Pruritus—Triamcinolone—hematologic cancer	4.3e-05	0.000281	CcSEcCtD
Fexofenadine—Cough—Methotrexate—hematologic cancer	4.3e-05	0.00028	CcSEcCtD
Fexofenadine—Vomiting—Etoposide—hematologic cancer	4.26e-05	0.000278	CcSEcCtD
Fexofenadine—Agitation—Epirubicin—hematologic cancer	4.23e-05	0.000276	CcSEcCtD
Fexofenadine—Dyspepsia—Prednisone—hematologic cancer	4.23e-05	0.000276	CcSEcCtD
Fexofenadine—Rash—Etoposide—hematologic cancer	4.23e-05	0.000276	CcSEcCtD
Fexofenadine—Dermatitis—Etoposide—hematologic cancer	4.23e-05	0.000276	CcSEcCtD
Fexofenadine—Headache—Etoposide—hematologic cancer	4.2e-05	0.000274	CcSEcCtD
Fexofenadine—Flatulence—Doxorubicin—hematologic cancer	4.2e-05	0.000274	CcSEcCtD
Fexofenadine—Myalgia—Methotrexate—hematologic cancer	4.19e-05	0.000273	CcSEcCtD
Fexofenadine—Tension—Doxorubicin—hematologic cancer	4.18e-05	0.000273	CcSEcCtD
Fexofenadine—Rash—Prednisolone—hematologic cancer	4.17e-05	0.000272	CcSEcCtD
Fexofenadine—Dermatitis—Prednisolone—hematologic cancer	4.17e-05	0.000272	CcSEcCtD
Fexofenadine—Fatigue—Prednisone—hematologic cancer	4.14e-05	0.00027	CcSEcCtD
Fexofenadine—Headache—Prednisolone—hematologic cancer	4.14e-05	0.00027	CcSEcCtD
Fexofenadine—Nervousness—Doxorubicin—hematologic cancer	4.14e-05	0.00027	CcSEcCtD
Fexofenadine—Back pain—Doxorubicin—hematologic cancer	4.12e-05	0.000269	CcSEcCtD
Fexofenadine—Palpitations—Epirubicin—hematologic cancer	4.07e-05	0.000265	CcSEcCtD
Fexofenadine—Dizziness—Triamcinolone—hematologic cancer	4.02e-05	0.000262	CcSEcCtD
Fexofenadine—Cough—Epirubicin—hematologic cancer	4.02e-05	0.000262	CcSEcCtD
Fexofenadine—Anaphylactic shock—Methotrexate—hematologic cancer	4.02e-05	0.000262	CcSEcCtD
Fexofenadine—Vision blurred—Doxorubicin—hematologic cancer	4.02e-05	0.000262	CcSEcCtD
Fexofenadine—Infection—Methotrexate—hematologic cancer	3.99e-05	0.00026	CcSEcCtD
Fexofenadine—Nausea—Etoposide—hematologic cancer	3.98e-05	0.00026	CcSEcCtD
Fexofenadine—Asthenia—Dexamethasone—hematologic cancer	3.96e-05	0.000258	CcSEcCtD
Fexofenadine—Asthenia—Betamethasone—hematologic cancer	3.96e-05	0.000258	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Prednisone—hematologic cancer	3.93e-05	0.000256	CcSEcCtD
Fexofenadine—Nausea—Prednisolone—hematologic cancer	3.93e-05	0.000256	CcSEcCtD
Fexofenadine—Myalgia—Epirubicin—hematologic cancer	3.92e-05	0.000256	CcSEcCtD
Fexofenadine—Agitation—Doxorubicin—hematologic cancer	3.92e-05	0.000255	CcSEcCtD
Fexofenadine—Pruritus—Dexamethasone—hematologic cancer	3.91e-05	0.000255	CcSEcCtD
Fexofenadine—Pruritus—Betamethasone—hematologic cancer	3.91e-05	0.000255	CcSEcCtD
Fexofenadine—Vomiting—Triamcinolone—hematologic cancer	3.87e-05	0.000252	CcSEcCtD
Fexofenadine—Rash—Triamcinolone—hematologic cancer	3.84e-05	0.00025	CcSEcCtD
Fexofenadine—Dry mouth—Epirubicin—hematologic cancer	3.84e-05	0.00025	CcSEcCtD
Fexofenadine—Dermatitis—Triamcinolone—hematologic cancer	3.83e-05	0.00025	CcSEcCtD
Fexofenadine—Urticaria—Prednisone—hematologic cancer	3.82e-05	0.000249	CcSEcCtD
Fexofenadine—Headache—Triamcinolone—hematologic cancer	3.81e-05	0.000249	CcSEcCtD
Fexofenadine—Body temperature increased—Prednisone—hematologic cancer	3.8e-05	0.000248	CcSEcCtD
Fexofenadine—Abdominal pain—Prednisone—hematologic cancer	3.8e-05	0.000248	CcSEcCtD
Fexofenadine—Diarrhoea—Dexamethasone—hematologic cancer	3.78e-05	0.000246	CcSEcCtD
Fexofenadine—Diarrhoea—Betamethasone—hematologic cancer	3.78e-05	0.000246	CcSEcCtD
Fexofenadine—Palpitations—Doxorubicin—hematologic cancer	3.77e-05	0.000246	CcSEcCtD
Fexofenadine—Anaphylactic shock—Epirubicin—hematologic cancer	3.76e-05	0.000245	CcSEcCtD
Fexofenadine—Infection—Epirubicin—hematologic cancer	3.74e-05	0.000244	CcSEcCtD
Fexofenadine—Cough—Doxorubicin—hematologic cancer	3.72e-05	0.000243	CcSEcCtD
Fexofenadine—Tachycardia—Epirubicin—hematologic cancer	3.67e-05	0.000239	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.66e-05	0.000239	CcSEcCtD
Fexofenadine—Dizziness—Dexamethasone—hematologic cancer	3.65e-05	0.000238	CcSEcCtD
Fexofenadine—Dizziness—Betamethasone—hematologic cancer	3.65e-05	0.000238	CcSEcCtD
Fexofenadine—Insomnia—Methotrexate—hematologic cancer	3.63e-05	0.000237	CcSEcCtD
Fexofenadine—Myalgia—Doxorubicin—hematologic cancer	3.63e-05	0.000237	CcSEcCtD
Fexofenadine—Nausea—Triamcinolone—hematologic cancer	3.61e-05	0.000236	CcSEcCtD
Fexofenadine—Dyspnoea—Methotrexate—hematologic cancer	3.58e-05	0.000234	CcSEcCtD
Fexofenadine—Somnolence—Methotrexate—hematologic cancer	3.57e-05	0.000233	CcSEcCtD
Fexofenadine—Dry mouth—Doxorubicin—hematologic cancer	3.55e-05	0.000231	CcSEcCtD
Fexofenadine—Hypersensitivity—Prednisone—hematologic cancer	3.54e-05	0.000231	CcSEcCtD
Fexofenadine—Dyspepsia—Methotrexate—hematologic cancer	3.54e-05	0.000231	CcSEcCtD
Fexofenadine—Vomiting—Betamethasone—hematologic cancer	3.51e-05	0.000229	CcSEcCtD
Fexofenadine—Vomiting—Dexamethasone—hematologic cancer	3.51e-05	0.000229	CcSEcCtD
Fexofenadine—Rash—Betamethasone—hematologic cancer	3.48e-05	0.000227	CcSEcCtD
Fexofenadine—Rash—Dexamethasone—hematologic cancer	3.48e-05	0.000227	CcSEcCtD
Fexofenadine—Anaphylactic shock—Doxorubicin—hematologic cancer	3.48e-05	0.000227	CcSEcCtD
Fexofenadine—Dermatitis—Dexamethasone—hematologic cancer	3.48e-05	0.000227	CcSEcCtD
Fexofenadine—Dermatitis—Betamethasone—hematologic cancer	3.48e-05	0.000227	CcSEcCtD
Fexofenadine—Fatigue—Methotrexate—hematologic cancer	3.46e-05	0.000226	CcSEcCtD
Fexofenadine—Headache—Betamethasone—hematologic cancer	3.46e-05	0.000226	CcSEcCtD
Fexofenadine—Headache—Dexamethasone—hematologic cancer	3.46e-05	0.000226	CcSEcCtD
Fexofenadine—Infection—Doxorubicin—hematologic cancer	3.46e-05	0.000225	CcSEcCtD
Fexofenadine—Asthenia—Prednisone—hematologic cancer	3.45e-05	0.000225	CcSEcCtD
Fexofenadine—Pain—Methotrexate—hematologic cancer	3.44e-05	0.000224	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.43e-05	0.000223	CcSEcCtD
Fexofenadine—Pruritus—Prednisone—hematologic cancer	3.4e-05	0.000222	CcSEcCtD
Fexofenadine—Insomnia—Epirubicin—hematologic cancer	3.4e-05	0.000222	CcSEcCtD
Fexofenadine—Tachycardia—Doxorubicin—hematologic cancer	3.4e-05	0.000221	CcSEcCtD
Fexofenadine—Dyspnoea—Epirubicin—hematologic cancer	3.35e-05	0.000219	CcSEcCtD
Fexofenadine—Somnolence—Epirubicin—hematologic cancer	3.34e-05	0.000218	CcSEcCtD
Fexofenadine—Dyspepsia—Epirubicin—hematologic cancer	3.31e-05	0.000216	CcSEcCtD
Fexofenadine—Diarrhoea—Prednisone—hematologic cancer	3.29e-05	0.000214	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Methotrexate—hematologic cancer	3.29e-05	0.000214	CcSEcCtD
Fexofenadine—Nausea—Dexamethasone—hematologic cancer	3.28e-05	0.000214	CcSEcCtD
Fexofenadine—Nausea—Betamethasone—hematologic cancer	3.28e-05	0.000214	CcSEcCtD
Fexofenadine—Fatigue—Epirubicin—hematologic cancer	3.24e-05	0.000211	CcSEcCtD
Fexofenadine—Pain—Epirubicin—hematologic cancer	3.22e-05	0.00021	CcSEcCtD
Fexofenadine—Urticaria—Methotrexate—hematologic cancer	3.19e-05	0.000208	CcSEcCtD
Fexofenadine—Dizziness—Prednisone—hematologic cancer	3.18e-05	0.000207	CcSEcCtD
Fexofenadine—Abdominal pain—Methotrexate—hematologic cancer	3.18e-05	0.000207	CcSEcCtD
Fexofenadine—Body temperature increased—Methotrexate—hematologic cancer	3.18e-05	0.000207	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.17e-05	0.000207	CcSEcCtD
Fexofenadine—Insomnia—Doxorubicin—hematologic cancer	3.15e-05	0.000205	CcSEcCtD
Fexofenadine—Dyspnoea—Doxorubicin—hematologic cancer	3.1e-05	0.000202	CcSEcCtD
Fexofenadine—Somnolence—Doxorubicin—hematologic cancer	3.09e-05	0.000202	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Epirubicin—hematologic cancer	3.07e-05	0.0002	CcSEcCtD
Fexofenadine—Dyspepsia—Doxorubicin—hematologic cancer	3.06e-05	0.0002	CcSEcCtD
Fexofenadine—Vomiting—Prednisone—hematologic cancer	3.06e-05	0.000199	CcSEcCtD
Fexofenadine—Rash—Prednisone—hematologic cancer	3.03e-05	0.000198	CcSEcCtD
Fexofenadine—Dermatitis—Prednisone—hematologic cancer	3.03e-05	0.000197	CcSEcCtD
Fexofenadine—Headache—Prednisone—hematologic cancer	3.01e-05	0.000196	CcSEcCtD
Fexofenadine—Fatigue—Doxorubicin—hematologic cancer	3e-05	0.000196	CcSEcCtD
Fexofenadine—Urticaria—Epirubicin—hematologic cancer	2.99e-05	0.000195	CcSEcCtD
Fexofenadine—Pain—Doxorubicin—hematologic cancer	2.97e-05	0.000194	CcSEcCtD
Fexofenadine—Abdominal pain—Epirubicin—hematologic cancer	2.97e-05	0.000194	CcSEcCtD
Fexofenadine—Body temperature increased—Epirubicin—hematologic cancer	2.97e-05	0.000194	CcSEcCtD
Fexofenadine—Hypersensitivity—Methotrexate—hematologic cancer	2.96e-05	0.000193	CcSEcCtD
Fexofenadine—Asthenia—Methotrexate—hematologic cancer	2.88e-05	0.000188	CcSEcCtD
Fexofenadine—Nausea—Prednisone—hematologic cancer	2.86e-05	0.000186	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.84e-05	0.000186	CcSEcCtD
Fexofenadine—Pruritus—Methotrexate—hematologic cancer	2.84e-05	0.000185	CcSEcCtD
Fexofenadine—Hypersensitivity—Epirubicin—hematologic cancer	2.77e-05	0.000181	CcSEcCtD
Fexofenadine—Urticaria—Doxorubicin—hematologic cancer	2.76e-05	0.00018	CcSEcCtD
Fexofenadine—Abdominal pain—Doxorubicin—hematologic cancer	2.75e-05	0.000179	CcSEcCtD
Fexofenadine—Body temperature increased—Doxorubicin—hematologic cancer	2.75e-05	0.000179	CcSEcCtD
Fexofenadine—Diarrhoea—Methotrexate—hematologic cancer	2.75e-05	0.000179	CcSEcCtD
Fexofenadine—Asthenia—Epirubicin—hematologic cancer	2.7e-05	0.000176	CcSEcCtD
Fexofenadine—Pruritus—Epirubicin—hematologic cancer	2.66e-05	0.000173	CcSEcCtD
Fexofenadine—Dizziness—Methotrexate—hematologic cancer	2.66e-05	0.000173	CcSEcCtD
Fexofenadine—Diarrhoea—Epirubicin—hematologic cancer	2.57e-05	0.000168	CcSEcCtD
Fexofenadine—Hypersensitivity—Doxorubicin—hematologic cancer	2.56e-05	0.000167	CcSEcCtD
Fexofenadine—Vomiting—Methotrexate—hematologic cancer	2.55e-05	0.000167	CcSEcCtD
Fexofenadine—Rash—Methotrexate—hematologic cancer	2.53e-05	0.000165	CcSEcCtD
Fexofenadine—Dermatitis—Methotrexate—hematologic cancer	2.53e-05	0.000165	CcSEcCtD
Fexofenadine—Headache—Methotrexate—hematologic cancer	2.52e-05	0.000164	CcSEcCtD
Fexofenadine—Asthenia—Doxorubicin—hematologic cancer	2.5e-05	0.000163	CcSEcCtD
Fexofenadine—Dizziness—Epirubicin—hematologic cancer	2.49e-05	0.000162	CcSEcCtD
Fexofenadine—Pruritus—Doxorubicin—hematologic cancer	2.46e-05	0.000161	CcSEcCtD
Fexofenadine—Vomiting—Epirubicin—hematologic cancer	2.39e-05	0.000156	CcSEcCtD
Fexofenadine—Nausea—Methotrexate—hematologic cancer	2.39e-05	0.000156	CcSEcCtD
Fexofenadine—Diarrhoea—Doxorubicin—hematologic cancer	2.38e-05	0.000155	CcSEcCtD
Fexofenadine—Rash—Epirubicin—hematologic cancer	2.37e-05	0.000155	CcSEcCtD
Fexofenadine—Dermatitis—Epirubicin—hematologic cancer	2.37e-05	0.000154	CcSEcCtD
Fexofenadine—Headache—Epirubicin—hematologic cancer	2.36e-05	0.000154	CcSEcCtD
Fexofenadine—Dizziness—Doxorubicin—hematologic cancer	2.3e-05	0.00015	CcSEcCtD
Fexofenadine—Nausea—Epirubicin—hematologic cancer	2.23e-05	0.000146	CcSEcCtD
Fexofenadine—Vomiting—Doxorubicin—hematologic cancer	2.21e-05	0.000144	CcSEcCtD
Fexofenadine—Rash—Doxorubicin—hematologic cancer	2.19e-05	0.000143	CcSEcCtD
Fexofenadine—Dermatitis—Doxorubicin—hematologic cancer	2.19e-05	0.000143	CcSEcCtD
Fexofenadine—Headache—Doxorubicin—hematologic cancer	2.18e-05	0.000142	CcSEcCtD
Fexofenadine—Nausea—Doxorubicin—hematologic cancer	2.07e-05	0.000135	CcSEcCtD
Fexofenadine—HRH1—Signaling by GPCR—CSF2—hematologic cancer	7.59e-06	0.000172	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CG—hematologic cancer	7.54e-06	0.000171	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.53e-06	0.000171	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—IL2RA—hematologic cancer	7.53e-06	0.000171	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	7.51e-06	0.00017	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	7.49e-06	0.00017	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—XIAP—hematologic cancer	7.48e-06	0.00017	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ACP5—hematologic cancer	7.44e-06	0.000169	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CA9—hematologic cancer	7.44e-06	0.000169	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTP1—hematologic cancer	7.43e-06	0.000169	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NCOR2—hematologic cancer	7.34e-06	0.000167	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PRKCG—hematologic cancer	7.32e-06	0.000166	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—JAK1—hematologic cancer	7.32e-06	0.000166	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SH2B3—hematologic cancer	7.29e-06	0.000165	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SMARCA4—hematologic cancer	7.29e-06	0.000165	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GZMB—hematologic cancer	7.24e-06	0.000164	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ARNTL—hematologic cancer	7.21e-06	0.000164	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.19e-06	0.000163	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CTNNA1—hematologic cancer	7.07e-06	0.000161	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—MTHFR—hematologic cancer	7.05e-06	0.00016	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EIF4EBP1—hematologic cancer	7.03e-06	0.00016	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HSPB1—hematologic cancer	7.03e-06	0.00016	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCL3—hematologic cancer	7.03e-06	0.00016	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ABCB1—hematologic cancer	7.03e-06	0.00016	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CA9—hematologic cancer	7.01e-06	0.000159	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ACP5—hematologic cancer	7.01e-06	0.000159	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—IDH1—hematologic cancer	7e-06	0.000159	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—CREBBP—hematologic cancer	6.99e-06	0.000159	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	6.99e-06	0.000159	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTHLH—hematologic cancer	6.95e-06	0.000158	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SDC1—hematologic cancer	6.95e-06	0.000158	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	6.94e-06	0.000157	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NCOR2—hematologic cancer	6.92e-06	0.000157	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—TXN—hematologic cancer	6.92e-06	0.000157	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTO1—hematologic cancer	6.92e-06	0.000157	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ABCC3—hematologic cancer	6.92e-06	0.000157	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL2RA—hematologic cancer	6.84e-06	0.000155	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—GSTM1—hematologic cancer	6.83e-06	0.000155	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—NCOR1—hematologic cancer	6.83e-06	0.000155	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SPHK1—hematologic cancer	6.77e-06	0.000154	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTGER4—hematologic cancer	6.77e-06	0.000154	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—LCK—hematologic cancer	6.73e-06	0.000153	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CD—hematologic cancer	6.63e-06	0.000151	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—H3F3A—hematologic cancer	6.6e-06	0.00015	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—IDH1—hematologic cancer	6.59e-06	0.00015	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—ALB—hematologic cancer	6.55e-06	0.000149	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCC3—hematologic cancer	6.52e-06	0.000148	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—TXN—hematologic cancer	6.52e-06	0.000148	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTO1—hematologic cancer	6.52e-06	0.000148	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—UGT1A1—hematologic cancer	6.5e-06	0.000148	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRKCZ—hematologic cancer	6.42e-06	0.000146	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SPHK1—hematologic cancer	6.38e-06	0.000145	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	6.37e-06	0.000145	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CRABP1—hematologic cancer	6.33e-06	0.000144	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SLC22A1—hematologic cancer	6.33e-06	0.000144	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CG—hematologic cancer	6.27e-06	0.000142	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3R1—hematologic cancer	6.26e-06	0.000142	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.22e-06	0.000141	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PARP1—hematologic cancer	6.2e-06	0.000141	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALOX5—hematologic cancer	6.17e-06	0.00014	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	6.16e-06	0.00014	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	6.13e-06	0.000139	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FBXW7—hematologic cancer	6.1e-06	0.000138	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—MTHFR—hematologic cancer	6.03e-06	0.000137	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HDAC2—hematologic cancer	5.98e-06	0.000136	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CXCR4—hematologic cancer	5.98e-06	0.000136	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NUP98—hematologic cancer	5.97e-06	0.000136	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	5.96e-06	0.000135	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CRABP1—hematologic cancer	5.96e-06	0.000135	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CG—hematologic cancer	5.93e-06	0.000135	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CBL—hematologic cancer	5.83e-06	0.000132	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALOX5—hematologic cancer	5.81e-06	0.000132	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NCOA3—hematologic cancer	5.8e-06	0.000132	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ADCY7—hematologic cancer	5.8e-06	0.000132	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CB—hematologic cancer	5.78e-06	0.000131	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL3—hematologic cancer	5.77e-06	0.000131	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NUP214—hematologic cancer	5.76e-06	0.000131	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CG—hematologic cancer	5.7e-06	0.000129	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTPN1—hematologic cancer	5.67e-06	0.000129	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ABCG2—hematologic cancer	5.64e-06	0.000128	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MTR—hematologic cancer	5.64e-06	0.000128	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NUP98—hematologic cancer	5.63e-06	0.000128	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PTPN11—hematologic cancer	5.6e-06	0.000127	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—RASGRP1—hematologic cancer	5.58e-06	0.000127	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HSP90AA1—hematologic cancer	5.56e-06	0.000126	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SYK—hematologic cancer	5.56e-06	0.000126	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ENO2—hematologic cancer	5.53e-06	0.000126	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CD—hematologic cancer	5.51e-06	0.000125	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—CREBBP—hematologic cancer	5.49e-06	0.000125	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ADCY7—hematologic cancer	5.46e-06	0.000124	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NCOA3—hematologic cancer	5.46e-06	0.000124	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NUP214—hematologic cancer	5.42e-06	0.000123	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CREB1—hematologic cancer	5.42e-06	0.000123	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTT1—hematologic cancer	5.36e-06	0.000122	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STAT1—hematologic cancer	5.36e-06	0.000122	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.32e-06	0.000121	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MTR—hematologic cancer	5.31e-06	0.000121	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCG2—hematologic cancer	5.31e-06	0.000121	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—CCL2—hematologic cancer	5.31e-06	0.00012	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6R—hematologic cancer	5.29e-06	0.00012	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—SDC1—hematologic cancer	5.24e-06	0.000119	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ENO2—hematologic cancer	5.21e-06	0.000118	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CD—hematologic cancer	5.21e-06	0.000118	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3R1—hematologic cancer	5.21e-06	0.000118	CbGpPWpGaD
Fexofenadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.21e-06	0.000118	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—ALB—hematologic cancer	5.14e-06	0.000117	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	5.07e-06	0.000115	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—JAK2—hematologic cancer	5.06e-06	0.000115	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTT1—hematologic cancer	5.05e-06	0.000115	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MAP2K1—hematologic cancer	5.04e-06	0.000114	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.02e-06	0.000114	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—GRB2—hematologic cancer	5.01e-06	0.000114	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CD—hematologic cancer	5.01e-06	0.000114	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PDGFA—hematologic cancer	5e-06	0.000114	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PTEN—hematologic cancer	4.99e-06	0.000113	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—SDC1—hematologic cancer	4.94e-06	0.000112	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KITLG—hematologic cancer	4.93e-06	0.000112	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	4.92e-06	0.000112	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STAT5A—hematologic cancer	4.82e-06	0.000109	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CB—hematologic cancer	4.81e-06	0.000109	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN2B—hematologic cancer	4.78e-06	0.000108	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—EP300—hematologic cancer	4.76e-06	0.000108	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3R1—hematologic cancer	4.73e-06	0.000107	CbGpPWpGaD
Fexofenadine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.7e-06	0.000107	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—CREBBP—hematologic cancer	4.7e-06	0.000107	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CD86—hematologic cancer	4.62e-06	0.000105	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—JAK2—hematologic cancer	4.6e-06	0.000104	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HES1—hematologic cancer	4.56e-06	0.000103	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	4.54e-06	0.000103	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NCOR1—hematologic cancer	4.53e-06	0.000103	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGF1—hematologic cancer	4.48e-06	0.000102	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CSF2—hematologic cancer	4.48e-06	0.000102	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CD44—hematologic cancer	4.46e-06	0.000101	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NQO1—hematologic cancer	4.46e-06	0.000101	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	4.46e-06	0.000101	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FOXO1—hematologic cancer	4.42e-06	0.0001	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—IL2—hematologic cancer	4.41e-06	0.0001	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PDGFRB—hematologic cancer	4.41e-06	0.0001	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—ALB—hematologic cancer	4.4e-06	9.98e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CB—hematologic cancer	4.36e-06	9.91e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PDGFRA—hematologic cancer	4.34e-06	9.85e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JAK1—hematologic cancer	4.32e-06	9.82e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PRKCG—hematologic cancer	4.32e-06	9.82e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CYCS—hematologic cancer	4.22e-06	9.58e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	4.21e-06	9.55e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CD44—hematologic cancer	4.2e-06	9.54e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NQO1—hematologic cancer	4.2e-06	9.54e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.19e-06	9.51e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL2RA—hematologic cancer	4.04e-06	9.17e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL2—hematologic cancer	4.01e-06	9.1e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TERT—hematologic cancer	3.99e-06	9.07e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CYCS—hematologic cancer	3.98e-06	9.02e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.95e-06	8.97e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PTEN—hematologic cancer	3.92e-06	8.91e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PDGFB—hematologic cancer	3.9e-06	8.85e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	3.88e-06	8.82e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TSC2—hematologic cancer	3.81e-06	8.65e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—EP300—hematologic cancer	3.74e-06	8.5e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTP1—hematologic cancer	3.72e-06	8.44e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGFR3—hematologic cancer	3.67e-06	8.32e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK14—hematologic cancer	3.63e-06	8.24e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—ESR1—hematologic cancer	3.56e-06	8.08e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	3.52e-06	8e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FN1—hematologic cancer	3.52e-06	7.98e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.5e-06	7.95e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NFKBIA—hematologic cancer	3.47e-06	7.89e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—BAD—hematologic cancer	3.47e-06	7.89e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NOTCH1—hematologic cancer	3.44e-06	7.81e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—NCOR1—hematologic cancer	3.42e-06	7.76e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—GSTM1—hematologic cancer	3.42e-06	7.76e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CD80—hematologic cancer	3.37e-06	7.65e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CG—hematologic cancer	3.36e-06	7.64e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KIT—hematologic cancer	3.36e-06	7.64e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—NRAS—hematologic cancer	3.36e-06	7.64e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PTEN—hematologic cancer	3.36e-06	7.62e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.32e-06	7.53e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTPN11—hematologic cancer	3.31e-06	7.5e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—MAPK3—hematologic cancer	3.22e-06	7.32e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.22e-06	7.31e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.22e-06	7.31e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CREB1—hematologic cancer	3.2e-06	7.27e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—EP300—hematologic cancer	3.2e-06	7.26e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—BRAF—hematologic cancer	3.16e-06	7.18e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCL2—hematologic cancer	3.13e-06	7.11e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6R—hematologic cancer	3.12e-06	7.09e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CREBBP—hematologic cancer	3.12e-06	7.08e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—MTHFR—hematologic cancer	3.02e-06	6.85e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAP2K1—hematologic cancer	2.98e-06	6.76e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CD—hematologic cancer	2.96e-06	6.72e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.93e-06	6.65e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—KRAS—hematologic cancer	2.9e-06	6.57e-05	CbGpPWpGaD
Fexofenadine—SLCO1B3—Metabolism—AKT1—hematologic cancer	2.88e-06	6.53e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.85e-06	6.46e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—FGF2—hematologic cancer	2.83e-06	6.43e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3R1—hematologic cancer	2.79e-06	6.34e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	2.77e-06	6.28e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JAK2—hematologic cancer	2.71e-06	6.16e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—PIK3CA—hematologic cancer	2.66e-06	6.04e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MDM2—hematologic cancer	2.65e-06	6.02e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MTOR—hematologic cancer	2.58e-06	5.85e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CB—hematologic cancer	2.58e-06	5.85e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.54e-06	5.76e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—HRAS—hematologic cancer	2.46e-06	5.59e-05	CbGpPWpGaD
Fexofenadine—Lomitapide—ABCB1—hematologic cancer	2.43e-06	0.515	CrCbGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN1B—hematologic cancer	2.42e-06	5.49e-05	CbGpPWpGaD
Fexofenadine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	2.39e-06	5.43e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.39e-06	5.43e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CASP3—hematologic cancer	2.37e-06	5.38e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL2—hematologic cancer	2.37e-06	5.38e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	2.37e-06	5.37e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—IL6—hematologic cancer	2.36e-06	5.35e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—CREBBP—hematologic cancer	2.35e-06	5.34e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CCND1—hematologic cancer	2.31e-06	5.24e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—JUN—hematologic cancer	2.3e-06	5.23e-05	CbGpPWpGaD
Fexofenadine—SLCO1A2—Metabolism—AKT1—hematologic cancer	2.26e-06	5.13e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	2.23e-06	5.07e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.23e-06	5.06e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PTEN—hematologic cancer	2.23e-06	5.06e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.22e-06	5.03e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—ALB—hematologic cancer	2.2e-06	5e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	2.18e-06	4.95e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	2.17e-06	4.93e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—EP300—hematologic cancer	2.12e-06	4.82e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.11e-06	4.78e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.1e-06	4.77e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—ALB—hematologic cancer	2.07e-06	4.71e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—SRC—hematologic cancer	2.07e-06	4.69e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	2.01e-06	4.57e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—STAT3—hematologic cancer	1.99e-06	4.52e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—NRAS—hematologic cancer	1.99e-06	4.51e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.98e-06	4.51e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.94e-06	4.41e-05	CbGpPWpGaD
Fexofenadine—SLCO1B1—Metabolism—AKT1—hematologic cancer	1.93e-06	4.39e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	1.9e-06	4.32e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—MYC—hematologic cancer	1.85e-06	4.2e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	1.85e-06	4.19e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.83e-06	4.16e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—KRAS—hematologic cancer	1.71e-06	3.88e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PTEN—hematologic cancer	1.68e-06	3.81e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—EP300—hematologic cancer	1.6e-06	3.64e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.58e-06	3.59e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	1.57e-06	3.57e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—TP53—hematologic cancer	1.52e-06	3.45e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—EP300—hematologic cancer	1.51e-06	3.43e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—HRAS—hematologic cancer	1.45e-06	3.3e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—IL6—hematologic cancer	1.39e-06	3.16e-05	CbGpPWpGaD
Fexofenadine—HRH1—Signaling Pathways—AKT1—hematologic cancer	1.28e-06	2.91e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.19e-06	2.69e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.12e-06	2.54e-05	CbGpPWpGaD
Fexofenadine—ABCB1—Metabolism—AKT1—hematologic cancer	9.68e-07	2.2e-05	CbGpPWpGaD
Fexofenadine—CYP2D6—Metabolism—AKT1—hematologic cancer	9.12e-07	2.07e-05	CbGpPWpGaD
Fexofenadine—Pimozide—ABCB1—hematologic cancer	6.92e-07	0.147	CrCbGaD
Fexofenadine—Fentanyl—ABCB1—hematologic cancer	6e-07	0.127	CrCbGaD
Fexofenadine—Loperamide—ABCB1—hematologic cancer	5.78e-07	0.123	CrCbGaD
Fexofenadine—Methadone—ABCB1—hematologic cancer	4.11e-07	0.0874	CrCbGaD
